TWI372059B - Pharmaceutical compositions for treating diseases associated with angiogenesis and inflammation - Google Patents

Pharmaceutical compositions for treating diseases associated with angiogenesis and inflammation

Info

Publication number
TWI372059B
TWI372059B TW097149155A TW97149155A TWI372059B TW I372059 B TWI372059 B TW I372059B TW 097149155 A TW097149155 A TW 097149155A TW 97149155 A TW97149155 A TW 97149155A TW I372059 B TWI372059 B TW I372059B
Authority
TW
Taiwan
Prior art keywords
angiogenesis
inflammation
pharmaceutical compositions
diseases associated
treating diseases
Prior art date
Application number
TW097149155A
Other languages
English (en)
Other versions
TW200927162A (en
Inventor
Chiwen Chang
Original Assignee
Chiwen Chang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiwen Chang filed Critical Chiwen Chang
Publication of TW200927162A publication Critical patent/TW200927162A/zh
Application granted granted Critical
Publication of TWI372059B publication Critical patent/TWI372059B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW097149155A 2007-12-24 2008-12-17 Pharmaceutical compositions for treating diseases associated with angiogenesis and inflammation TWI372059B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/963,912 US20080171033A1 (en) 2004-08-26 2007-12-24 Compositions and methods for treating diseases associated with angiogenesis and inflammation

Publications (2)

Publication Number Publication Date
TW200927162A TW200927162A (en) 2009-07-01
TWI372059B true TWI372059B (en) 2012-09-11

Family

ID=40801745

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097149155A TWI372059B (en) 2007-12-24 2008-12-17 Pharmaceutical compositions for treating diseases associated with angiogenesis and inflammation

Country Status (5)

Country Link
US (2) US20080171033A1 (zh)
EP (1) EP2244723B1 (zh)
JP (1) JP5555176B2 (zh)
TW (1) TWI372059B (zh)
WO (1) WO2009082641A2 (zh)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
DE69434115T2 (de) * 1993-03-25 2005-10-27 Merck & Co., Inc. Inhibitor des wachstumsfaktors für gefässendothelzellen
US6265551B1 (en) * 1995-06-01 2001-07-24 Dana-Farber Cancer Institute, Inc. Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof
US6325989B1 (en) * 1995-06-01 2001-12-04 Dana-Farber Cancer Institute, Inc. Form of dipeptidylpeptidase IV (CD26) found in human serum
US6100071A (en) * 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
AU1616499A (en) * 1997-12-01 1999-06-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Chemokine variants and methods of use
WO1999047152A2 (en) * 1998-03-20 1999-09-23 Sloan Kettering Institute For Cancer Research Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
AU2003302017A1 (en) * 2002-05-17 2004-06-15 Board Of Regents, The University Of Texas System Cd26-based therapies for cancers and immune disease
US20060234969A1 (en) * 2003-03-07 2006-10-19 Anges Mg, Inc. Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasia
WO2004078786A1 (en) * 2003-03-07 2004-09-16 Anges Mg Inc. Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasia
WO2006026172A2 (en) * 2004-08-26 2006-03-09 Chang Chiwen Use of soluble cd26 as inhibitor of angiogenesis and inflammation
JP2009501521A (ja) * 2005-07-13 2009-01-22 ベス イスラエル ディーコネス メディカル センター 炎症応答を診断および処置する方法
WO2007041614A2 (en) * 2005-10-03 2007-04-12 Bolder Biotechnology, Inc. Long acting vegf inhibitors and methods of use

Also Published As

Publication number Publication date
US20100087378A1 (en) 2010-04-08
EP2244723B1 (en) 2013-10-02
JP5555176B2 (ja) 2014-07-23
JP2011507960A (ja) 2011-03-10
WO2009082641A3 (en) 2009-08-20
TW200927162A (en) 2009-07-01
EP2244723A2 (en) 2010-11-03
US20080171033A1 (en) 2008-07-17
WO2009082641A2 (en) 2009-07-02
US8846621B2 (en) 2014-09-30
EP2244723A4 (en) 2011-09-21

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
IL255752B (en) Compounds, pharmaceutical preparations containing the same uses for the treatment of cardiovascular disease, inflammatory diseases and cancer
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
EP2144612A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH MITOCHONDRIAL FUNCTION
EP2184986A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY
EP2214707A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION
EP2497482A4 (en) COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES
IL209216A (en) Preparations for the prevention and treatment of neurodegenerative diseases
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
EP2154966A4 (en) BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
EP2419399A4 (en) COMPOSITIONS AND METHOD FOR TREATING INFLAMMATION
HK1166633A1 (zh) 茚酮衍生物和包含它的藥物組合物
IL211842A (en) Antibodies or fragments of their human tgfbrii, pharmacological preparations containing them and their use in the preparation of a drug for inhibiting anogenesis
ZA201200944B (en) Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
ZA201004030B (en) Pharmaceutical compositions for treating depression and anxiety
HK1171677A1 (zh) 用於治療痔及相關疾病的組合物
EP2040726A4 (en) COMPOSITION OF TRACHELOSPERMI CAULIS EXTRACT FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
EP2321265A4 (en) INOSITOL AND TREHALOSE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES COMPRISING THESE DERIVATIVES
EP2004164A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE DISORDERS OR INFLAMMATORY DISORDERS
EP2402333A4 (en) 1,4-BENZOTHIAZEPINE 1-OXIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION USING THE SAME
EP2124980A4 (en) COMPOSITION WITH TRACHELOSPERMI CAULIS AND PYROLA JAPONICA EXTRACTS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
ZA201204341B (en) Pharmaceutical composition for treating gutaneous burns
HK1145399A1 (en) Pharmaceutical composition for treating hemorrhoids
TWI372059B (en) Pharmaceutical compositions for treating diseases associated with angiogenesis and inflammation
EP2344528A4 (en) DRUGS AND FIBROSIS, ITS COMPOSITION AND USES